Company News

 

Tauriga Invests In VistaGen (VTGN)
320,000 share equity position includes warrants …

Read More


Tauriga Invests In Blink (BLNK) BLINK is the largest Independent Electric Vehicle Charging Station Network..  Read More


Joint Venture With Ice and Jam Tauriga Will Split Profits 50/50 on Herman… Read More

Welcome To Tauriga Sciences

Tauriga Sciences would like to thank all its loyal shareholders. The last few years have been difficult,  primarily due negative consequences  subsequent to the July 2015 PCAOB public censure of Tauriga’s  former auditors, Cowan Gutenski. Tauriga Sciences settled the lawsuit against its former auditors in the 4th quarter of 2017 and there are several press releases detailing both the lawsuit and the settlement. Looking towards the future The Tauriga Sciences Board of Directors have taken advantage of several opportunities which could dramatically improve shareholder value and be valuable in negotiating any M&A. Please refer to the numerous press releases that the Company has put out regarding the the Company’s goal of a potential successful M&A.

Herman Capucua Lip Balm

Herman Lip Balm – the Company entered into a 50 / 50 partnership with Ice and Jam to distribute an exciting lip balm that is 100% organic and made from Capuaca Butter. Capuaca Butter is an amazing moisturizer with natural sunscreen protection. Read more here!

Currently the options for having a pure Cupacuaca lip balm are few.  Ice and Jam believs it has a superior formulation and has very little competition in the Cuapuaco lip balm space. The properties of Cuapacua make it an excellent solution for hours of moisturizing lip relief along with its natural sunscreen properties. The lip balm industry is a billion dollar industry and more and more the trend towards chemical free  superior natural and organic alternatives is growing.

Tauriga will attempt to market Herman through long standing relationships and assist Ice and Jam in cultivating relationships with local and national retailers as well as online channels.

Investments

 

VistaGen Therapeutics – The Company took an equity position in a Biotech company called VistaGen Therapeutics. The Company paid $1.50 per unit. a unit consists of 1 Common share at $1.50 and one Warrant exercisable at $1.50. VistaGen’s AV-101 compound is a potential blockbuster new class of drug to treat depression. The NIH is currently funding a Phase 2A trial and the FDA recently granted VistaGen fast track status. Read More about this exciting Company here!

 

Blink Charging – Blink is the largest owner, operator, and provider of electric vehicle charging stations in the United States. The Company has prime real estate locations and is capable of charging all brands, including Tesla. Read More About This Company Here!

 

Groestlecoin – Tauriga has also made a relatively small investment in the Crypto Currency Markets. ipurpose cryptocurrency that has Instant & Private transactions with subatomic fees. The Company believes this crypto currency offers superior technology as is extremely undervalued. Read More Here!

Recent Press Releases

NEW YORK, NY , March 13, 2018 (GLOBE NEWSWIRE) — Tauriga Sciences, Inc. (OTC PINK: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments,..

Read More
Tauriga Sciences Inc. Increases Equity Stake in Colorado Based NASDAQ Listed Biotechnology Firm Focused in the Medical Field of Urology

NEW YORK, NY, March 09, 2018 (GLOBE NEWSWIRE) — Tauriga Sciences, Inc. (OTC PINK: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today…

Read More
Tauriga Sciences Inc. Tenders One-Time Cash Payment of $43,045.00 to Fully Repay and Retire the Final Outstanding Convertible Debenture Held by Adar Bays, LLC

NEW YORK, NY, March 06, 2018 (GLOBE NEWSWIRE) — Tauriga Sciences, Inc. (OTC PINK: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today…

Read More

Fully committed to commercializing innovation to enhance personal wellness, improve our environment and create lasting shareholder value.